A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

A proposed cycle threshold value for viral abundance could help laboratories assess sample quality and potentially improve early variant detection ... “In response to the COVID-19 pandemic, NGS ...

while maintaining immunization protection against current and future COVID-19 variants and a benign tolerability profile. We thank BARDA for their strong leadership, partnership and funding to make ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced ... only during future outbreaks of ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Meanwhile, COVID activity remained low amid a shift in variant proportions and RSV levels rose in 3 US regions.

The CDC said several factors are probably contributing to a post-pandemic rise in pertussis activity. Aside from waning ...